This Week in PLOS

Scientists from across Italy this week report on their Sanger and next-generation sequencing-based investigation of a series of 116 non-small-cell lung cancer samples. "Our findings suggest that a region in exon 19 is highly unstable in a large proportion of patients carrying EGFR deletions," the authors write in PLOS One.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A former Synthetic Genomics attorney alleges that the firm discriminated against her and other female employees, according to the San Diego Union-Tribune.

Due to privacy and lab certification questions, the planned giveaway of Orig3n testing kits at a Baltimore Ravens game was suspended.

Alnylam reports positive results from its phase 3 clinical trial of an RNAi-based drug, according to Stat News.

In Cell this week: adult mesenchymal cell populations in mouse lung, genetic diversity in HPV16 and cancer risk protection, and more.